集采背景下公立医院与连锁药店药品供应情况的实证分析——以他汀类为例

Empirical Analysis of Drug Supply in Public Hospitals and Chain Drugstores under the Background of Volume Procurement——Take Statins as An Example

目的 考察“4+7”集采背景下公立医院与连锁药店药品供应情况,为推动“处方外流”的有效实现提供数据参考。方法 以他汀类为例,从“目录供应”和“价格水平”两个方面,对公立医院和连锁药店的药品供应情况进行实证分析。结果 目录供应方面,连锁药店的品种较公立医院有优势,能较好覆盖原研药和中选药。价格水平方面,从原研药看,社会药房的原研药较公立医院略贵,价格比为1.03~1.72,平均比值为1.30;从中选药看,社会药房的中选药价格明显高于公立医院,价格比为3.52~21.62,平均比值为14.05。结论 现时社会药房的价格,尤其中选药,较公立医院贵,建议从医保衔接、医院目录和药店供应三方面着手,继续推动处方外流。

Objective This study investigated drug supply in public hospitals and chain drugstores under the background of volume purchase, to provide reference for promoting "prescription outflow". Methods Taking statins as an example, the supply of drugs in public hospitals and chain drugstores was empirically analyzed from "catalogue supply" and "price level". Results In terms of catalog supply, chain drugstores had advantages over public hospitals, including original research drugs and selected drugs.In terms of price level, the original drugs in social pharmacies were slightly more expensive than those in public hospitals, with a price ratio ranging from 1.03 to 1.72, with an average of 1.30. However, the selected drugs in social pharmacies were far more expensive than those in public hospitals, with a price ratio ranging from 3.52 to 21.62, with an average of 14.05. Conclusion The price of social pharmacies, especially the selected drugs, is higher than that of public hospitals. It is suggested to continue to promote prescription outflow from three aspects: policy convergence, hospital catalogue and pharmacy supply.